Drug Shortage Report for SANDOZ PIRFENIDONE CAPSULES

Last updated on 2022-04-28 History
Report ID 159091
Drug Identification Number 02488833
Brand name SANDOZ PIRFENIDONE CAPSULES
Common or Proper name PIRFENIDONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PIRFENIDONE
Strength(s) 267MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 270HGC BO
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-04-20
Estimated end date Unknown
Actual end date 2022-04-28
Shortage status Resolved
Updated date 2022-04-28
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-04-28 French Compare
v3 2022-04-28 English Compare
v2 2022-04-20 French Compare
v1 2022-04-20 English Compare

Showing 1 to 4 of 4